Compelling evidence confirmed that blocking CD96 enhanced the containment of primary tumor growth in murine model systems in a CD8 + T cell-dependent manner (Dougall et al., 2017; Mittal et al., 2019). This evidence concerns the gene CD8A and neoplasm.